The DOI matches its Crossref record; 120 of the 120 references it cites were found in a registry or an index.
The molecular basis of neurodegeneration in multiple sclerosis
Open accessAbstract
Studies aimed to elucidate the pathogenesis of the disease and to find new therapeutic options for multiple sclerosis (MS) patients heavily rely on experimental autoimmune encephalomyelitis (EAE) as a suitable experimental model. This strategy has been highly successful for the inflammatory component of the disease, but had so far little success in the development of neuroprotective therapies, which are also effective in the progressive stage of the disease. Here we discuss opportunities and limitations of EAE models for MS research and provide an overview on the complex mechanisms leading to demyelination and neurodegeneration in this disease. We suggest that the underlying mechanisms involve adaptive and innate immunity. However, mitochondrial injury, resulting in energy failure, is a key element of neurodegeneration in MS and is apparently driven by radical production in activated microglia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
How mitochondria produce reactive oxygen species
Murphy, M. P. (2009) · Biochemical Journal · doi:10.1042/bj20081386 · Cited by 8,207
The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology
Bedard, K., & Krause, K.-H. (2007) · Physiological Reviews · doi:10.1152/physrev.00044.2005 · Cited by 6,989
McDonald, W. I., Compston, A., Edan, G., Goodkin, D., Hartung, H., Lublin, F. D., McFarland, H. F., Paty, D. W., Polman, C. H., Reingold, S. C., et al. (2001) · Annals of Neurology · doi:10.1002/ana.1032 · Cited by 6,969
Axonal transection in the lesions of multiple sclerosis
Trapp, B. D., Peterson, J., Ransohoff, R. M., Rudick, R., Mörk, S., & Bö, L. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801293380502 · Cited by 4,029
Defining the clinical course of multiple sclerosis: Results of an international survey
Lublin, F. D., Reingold, S. C., & National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis* (1996) · Neurology · doi:10.1212/wnl.46.4.907 · Cited by 3,686
Advances in metal-induced oxidative stress and human disease
Jomova, K., & Valko, M. (2011) · Toxicology · doi:10.1016/j.tox.2011.03.001 · Cited by 3,207
B-cell depletion with rituximab in relapsing-remitting multiple sclerosis
Hauser, S. L., Waubant, E., Arnold, D. L., Vollmer, T., Antel, J., Fox, R. J., Bar-Or, A., Panzara, M., Sarkar, N., Agarwal, S., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0706383 · Cited by 2,439
Cortical demyelination and diffuse white matter injury in multiple sclerosis
Kutzelnigg, A., Lucchinetti, C. F., Stadelmann, C., Brück, W., Rauschka, H., Bergmann, M., Schmidbauer, M., Parisi, J. E., & Lassmann, H. (2005) · Brain · doi:10.1093/brain/awh641 · Cited by 1,836
Self-citationAxonal damage in acute multiple sclerosis lesions
Ferguson, B. (1997) · Brain · doi:10.1093/brain/120.3.393 · Cited by 1,532
The relation between inflammation and neurodegeneration in multiple sclerosis brains
Frischer, J. M., Bramow, S., Dal-Bianco, A., Lucchinetti, C. F., Rauschka, H., Schmidbauer, M., Laursen, H., Sorensen, P. S., & Lassmann, H. (2009) · Brain · doi:10.1093/brain/awp070 · Cited by 1,450
Self-citationMagliozzi, R., Howell, O., Vora, A., Serafini, B., Nicholas, R., Puopolo, M., Reynolds, R., & Aloisi, F. (2006) · Brain · doi:10.1093/brain/awm038 · Cited by 1,443
The effect of age on the non-haemin iron in the human brain
Hallgren, B., & Sourander, P. (1958) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1958.tb12607.x · Cited by 1,427
Relapses and Progression of Disability in Multiple Sclerosis
Confavreux, C., Vukusic, S., Moreau, T., & Adeleine, P. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011163432001 · Cited by 1,309
Serafini, B., Rosicarelli, B., Magliozzi, R., Stigliano, E., & Aloisi, F. (2004) · Brain Pathology · doi:10.1111/j.1750-3639.2004.tb00049.x · Cited by 1,208
Relapsing and remitting multiple sclerosis: Pathology of the newly forming lesion
Barnett, M. H., & Prineas, J. W. (2004) · Annals of Neurology · doi:10.1002/ana.20016 · Cited by 1,185
The Immunopathology of Multiple Sclerosis: An Overview
Lassmann, H., Brück, W., & Lucchinetti, C. F. (2007) · Brain Pathology · doi:10.1111/j.1750-3639.2007.00064.x · Cited by 1,182
Self-citationLinker, R. A., Lee, D.-H., Ryan, S., van Dam, A. M., Conrad, R., Bista, P., Zeng, W., Hronowsky, X., Buko, A., Chollate, S., et al. (2011) · Brain · doi:10.1093/brain/awq386 · Cited by 1,155
Confavreux, C. (2003) · Brain · doi:10.1093/brain/awg081 · Cited by 996
Premyelinating Oligodendrocytes in Chronic Lesions of Multiple Sclerosis
Chang, A., Tourtellotte, W. W., Rudick, R., & Trapp, B. D. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa010994 · Cited by 991
Babbe, H., Roers, A., Waisman, A., Lassmann, H., Goebels, N., Hohlfeld, R., Friese, M., Schröder, R., Deckert, M., Schmidt, S., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.3.393 · Cited by 951
Self-citationMultiple Sclerosis and Chronic Autoimmune Encephalomyelitis
Kornek, B., Storch, M. K., Weissert, R., Wallstroem, E., Stefferl, A., Olsson, T., Linington, C., Schmidbauer, M., & Lassmann, H. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64537-3 · Cited by 921
Self-citationKuhlmann, T., Miron, V., Cuo, Q., Wegner, C., Antel, J., & Bruck, W. (2008) · Brain · doi:10.1093/brain/awn096 · Cited by 864
Iron-catalyzed hydroxyl radical formation. Stringent requirement for free iron coordination site.
Graf, E., Mahoney, J. R., Bryant, R. G., & Eaton, J. W. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)43139-5 · Cited by 855
Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients
Dutta, R., McDonough, J., Yin, X., Peterson, J., Chang, A., Torres, T., Gudz, T., Macklin, W. B., Lewis, D. A., Fox, R. J., et al. (2006) · Annals of Neurology · doi:10.1002/ana.20736 · Cited by 841
Remyelination is extensive in a subset of multiple sclerosis patients
Patrikios, P., Stadelmann, C., Kutzelnigg, A., Rauschka, H., Schmidbauer, M., Laursen, H., Sorensen, P. S., Bruck, W., Lucchinetti, C., & Lassmann, H. (2006) · Brain · doi:10.1093/brain/awl217 · Cited by 807
Self-citationOxidative damage in multiple sclerosis lesions
Haider, L., Fischer, M. T., Frischer, J. M., Bauer, J., Hoftberger, R., Botond, G., Esterbauer, H., Binder, C. J., Witztum, J. L., & Lassmann, H. (2011) · Brain · doi:10.1093/brain/awr128 · Cited by 753
Self-citationPanitch, H. S., Hirsch, R. L., Schindler, J., & Johnson, K. P. (1987) · Neurology · doi:10.1212/wnl.37.7.1097 · Cited by 751
A Gradient of neuronal loss and meningeal inflammation in multiple sclerosis
Magliozzi, R., Howell, O. W., Reeves, C., Roncaroli, F., Nicholas, R., Serafini, B., Aloisi, F., & Reynolds, R. (2010) · Annals of Neurology · doi:10.1002/ana.22230 · Cited by 747
A reversible form of axon damage in experimental autoimmune encephalomyelitis and multiple sclerosis
Nikić, I., Merkler, D., Sorbara, C., Brinkoetter, M., Kreutzfeldt, M., Bareyre, F. M., Brück, W., Bishop, D., Misgeld, T., & Kerschensteiner, M. (2011) · Nature Medicine · doi:10.1038/nm.2324 · Cited by 713
Linington, C., Bradl, M., Lassmann, H., Brunner, C., & Vass, K. (1988) · PubMed · Cited by 708
Self-citationOxidative Stress in Brain Ischemia
Love, S. (1999) · Brain Pathology · doi:10.1111/j.1750-3639.1999.tb00214.x · Cited by 685
Virtual hypoxia and chronic necrosis of demyelinated axons in multiple sclerosis
Trapp, B. D., & Stys, P. K. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70043-2 · Cited by 621
Demyelination: The Role of Reactive Oxygen and Nitrogen Species
Smith, K. J., Kapoor, R., & Felts, P. A. (1999) · Brain Pathology · doi:10.1111/j.1750-3639.1999.tb00212.x · Cited by 600
Chen, P.-C., Vargas, M. R., Pani, A. K., Smeyne, R. J., Johnson, D. A., Kan, Y. W., & Johnson, J. A. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0813361106 · Cited by 579
The role of nitric oxide in multiple sclerosis
Smith, K. J., & Lassmann, H. (2002) · The Lancet Neurology · doi:10.1016/s1474-4422(02)00102-3 · Cited by 531
Self-citationMonocyte/macrophage differentiation in early multiple sclerosis lesions
Brück, W., Porada, P., Poser, S., Rieckmann, P., Hanefeld, F., Kretzschmarch, H. A., & Lassmann, H. (1995) · Annals of Neurology · doi:10.1002/ana.410380514 · Cited by 530
Self-citationRituximab in relapsing‐remitting multiple sclerosis: A 72‐week, open‐label, phase I trial
Bar‐Or, A., Calabresi, P. A. J., Arnold, D., Markowitz, C., Shafer, S., Kasper, L. H., Waubant, E., Gazda, S., Fox, R. J., Panzara, M., et al. (2008) · Annals of Neurology · doi:10.1002/ana.21363 · Cited by 527
Bolaños, J. P., Almeida, A., Stewart, V., Peuchen, S., Land, J. M., Clark, J. B., & Heales, S. J. R. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.68062227.x · Cited by 519
Coles, A. J., Cox, A., Page, E., Jones, J., Trip, S. A., Deans, J., Seaman, S., Miller, D. H., Hale, G., Waldmann, H., et al. (2006) · Journal of Neurology · doi:10.1007/s00415-005-0934-5 · Cited by 506
Kappos, L., Gold, R., Miller, D. H., MacManus, D. G., Havrdova, E., Limmroth, V., Polman, C. H., Schmierer, K., Yousry, T. A., Yang, M., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61619-0 · Cited by 482
Cytotoxic T lymphocytes in autoimmune and degenerative CNS diseases
Neumann, H. (2002) · Trends in Neurosciences · doi:10.1016/s0166-2236(02)02154-9 · Cited by 480
Segal, B. M., Constantinescu, C. S., Raychaudhuri, A., Kim, L., Fidelus-Gort, R., & Kasper, L. H. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70173-x · Cited by 479
Bagasra, O., Michaels, F. H., Zheng, Y. M., Bobroski, L. E., Spitsin, S. V., Fu, Z. F., Tawadros, R., & Koprowski, H. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.26.12041 · Cited by 456
Mitochondrial changes within axons in multiple sclerosis
Mahad, D. J., Ziabreva, I., Campbell, G., Lax, N., White, K., Hanson, P. S., Lassmann, H., & Turnbull, D. M. (2009) · Brain · doi:10.1093/brain/awp046 · Cited by 454
Self-citationFlügel, A., Berkowicz, T., Ritter, T., Labeur, M., Jenne, D. E., Li, Z., Ellwart, J. W., Willem, M., Lassmann, H., & Wekerle, H. (2001) · Immunity · doi:10.1016/s1074-7613(01)00143-1 · Cited by 431
Self-citationde Vries, H. E., Witte, M., Hondius, D., Rozemuller, A. J. M., Drukarch, B., Hoozemans, J., & van Horssen, J. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.09.001 · Cited by 428
Self-citationFriese, M. A., Craner, M. J., Etzensperger, R., Vergo, S., Wemmie, J. A., Welsh, M. J., Vincent, A., & Fugger, L. (2007) · Nature Medicine · doi:10.1038/nm1668 · Cited by 408
Mitochondrial defects in acute multiple sclerosis lesions
Mahad, D., Ziabreva, I., Lassmann, H., & Turnbull, D. (2008) · Brain · doi:10.1093/brain/awn105 · Cited by 406
Self-citationMultiple sclerosis: Distribution of inflammatory cells in newly forming lesions
Henderson, A. P. D., Barnett, M. H., Parratt, J. D. E., & Prineas, J. W. (2009) · Annals of Neurology · doi:10.1002/ana.21800 · Cited by 387
Mitochondrial DNA deletions and neurodegeneration in multiple sclerosis
Campbell, G. R., Ziabreva, I., Reeve, A. K., Krishnan, K. J., Reynolds, R., Howell, O., Lassmann, H., Turnbull, D. M., & Mahad, D. J. (2011) · Annals of Neurology · doi:10.1002/ana.22109 · Cited by 386
Self-citationThe challenge of multiple sclerosis: How do we cure a chronic heterogeneous disease?
Weiner, H. L. (2009) · Annals of Neurology · doi:10.1002/ana.21640 · Cited by 344
Lu, F., Selak, M., O’Connor, J., Croul, S., Lorenzana, C., Butunoi, C., & Kalman, B. (2000) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(00)00343-9 · Cited by 331
Aboul-Enein, F., Rauschka, H., Kornek, B., Stadelmann, C., Stefferl, A., Brück, W., Lucchinetti, C., Schmidbauer, M., Jellinger, K., & Lassmann, H. (2003) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/62.1.25 · Cited by 330
Self-citationTHE NEUROPATHOLOGY OF MULTIPLE SCLEROSIS
Ludwin, S. K. (2000) · Neuroimaging Clinics of North America · doi:10.1016/s1052-5149(25)00665-3 · Cited by 329
Evangelou, N. (2001) · Brain · doi:10.1093/brain/124.9.1813 · Cited by 323
Radical changes in multiple sclerosis pathogenesis
van Horssen, J., Witte, M. E., Schreibelt, G., & de Vries, H. E. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.06.011 · Cited by 322
Self-citationBrilot, F., Dale, R. C., Selter, R. C., Grummel, V., Reddy Kalluri, S., Aslam, M., Busch, V., Zhou, D., Cepok, S., & Hemmer, B. (2009) · Annals of Neurology · doi:10.1002/ana.21916 · Cited by 322
van Horssen, J., Schreibelt, G., Drexhage, J., Hazes, T., Dijkstra, C. D., van der Valk, P., & de Vries, H. E. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.09.023 · Cited by 318
Self-citationWeber, M. S., Prod'homme, T., Patarroyo, J. C., Molnarfi, N., Karnezis, T., Lehmann‐Horn, K., Danilenko, D. M., Eastham‐Anderson, J., Slavin, A. J., Linington, C., et al. (2010) · Annals of Neurology · doi:10.1002/ana.22081 · Cited by 318
General mechanisms of axonal damage and its prevention
Stys, P. K. (2005) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2005.03.031 · Cited by 314
Expression of Inducible Nitric Oxide Synthase and Nitrotyrosine in Multiple Sclerosis Lesions
Liu, J. S.-H., Zhao, M.-L., Brosnan, C. F., & Lee, S. C. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64677-9 · Cited by 311
Comparative Neuropathology of Chronic Experimental Allergic Encephalomyelitis and Multiple Sclerosis
Lassmann, H. (1983) · Schriftenreihe Neurologie / Neurology Series · doi:10.1007/978-3-642-45558-2 · Cited by 296
Self-citationKanninen, K., Heikkinen, R., Malm, T., Rolova, T., Kuhmonen, S., Leinonen, H., Ylä-Herttuala, S., Tanila, H., Levonen, A.-L., Koistinaho, M., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0908397106 · Cited by 293
Lesion genesis in a subset of patients with multiple sclerosis: a role for innate immunity?
Marik, C., Felts, P. A., Bauer, J., Lassmann, H., & Smith, K. J. (2007) · Brain · doi:10.1093/brain/awm236 · Cited by 292
Self-citationAutoreactive CD8+ T cells in multiple sclerosis: a new target for therapy?
Friese, M. A., & Fugger, L. (2005) · Brain · doi:10.1093/brain/awh578 · Cited by 251
Hohlfeld, R., & Wekerle, H. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404874101 · Cited by 239
Mitochondrial dysfunction: A potential link between neuroinflammation and neurodegeneration?
Witte, M. E., Geurts, J. J. G., de Vries, H. E., van der Valk, P., & van Horssen, J. (2010) · Mitochondrion · doi:10.1016/j.mito.2010.05.014 · Cited by 235
Self-citationNeurotoxic Activation of Microglia Is Promoted by a Nox1-Dependent NADPH Oxidase
Chéret, C., Gervais, A., Lelli, A., Colin, C., Amar, L., Ravassard, P., Mallet, J., Cumano, A., Krause, K.-H., & Mallat, M. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.3568-08.2008 · Cited by 225
Enhanced number and activity of mitochondria in multiple sclerosis lesions
Witte, M. E., Bø, L., Rodenburg, R. J., Belien, J. A., Musters, R., Hazes, T., Wintjes, L. T., Smeitink, J. A., Geurts, J. J., De Vries, H. E., et al. (2009) · The Journal of Pathology · doi:10.1002/path.2582 · Cited by 225
Self-citationDerfuss, T., Parikh, K., Velhin, S., Braun, M., Mathey, E., Krumbholz, M., Kümpfel, T., Moldenhauer, A., Rader, C., Sonderegger, P., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0901496106 · Cited by 221
Self-citationJohnson, D. A., Amirahmadi, S., Ward, C., Fabry, Z., & Johnson, J. A. (2010) · Toxicological Sciences · doi:10.1093/toxsci/kfp274 · Cited by 203
Peroxynitrite formation within the central nervous system in active multiple sclerosis
Cross, A. H., Manning, P. T., Keeling, R. M., Schmidt, R. E., & Misko, T. P. (1998) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(98)00078-2 · Cited by 201
Iron deposits surrounding multiple sclerosis plaques.
Craelius, W., Mw, M., Luessenhop, C. P., Sugar, A. W., & Mihalakis, I. (1982) · PubMed · Cited by 197
Axonal Pathology in Multiple Sclerosis. A Historical Note
Kornek, B., & Lassmann, H. (1999) · Brain Pathology · doi:10.1111/j.1750-3639.1999.tb00547.x · Cited by 197
Self-citationReview: Mitochondria and disease progression in multiple sclerosis
Mahad, D., Lassmann, H., & Turnbull, D. (2008) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2008.00987.x · Cited by 193
Self-citationMicroglia and multiple sclerosis
Jack, C., Ruffini, F., Bar‐Or, A., & Antel, J. P. (2005) · Journal of Neuroscience Research · doi:10.1002/jnr.20482 · Cited by 193
Hendriks, J. J. A., Alblas, J., van der Pol, S. M. A., van Tol, E. A. F., Dijkstra, C. D., & de Vries, H. E. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040819 · Cited by 190
Kojima, K., Berger, T., Lassmann, H., Hinze-Selch, D., Zhang, Y., Gehrmann, J., Reske, K., Wekerle, H., & Linington, C. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.3.817 · Cited by 188
Self-citationBerger, T., Weerth, S., Kojima, K., Linington, C., Wekerle, H., & Lassmann, H. (1997) · PubMed · Cited by 185
Self-citationGray, E., Thomas, T. L., Betmouni, S., Scolding, N., & Love, S. (2008) · Brain Pathology · doi:10.1111/j.1750-3639.2007.00110.x · Cited by 175
Pathogenic CD8+ T cells in multiple sclerosis
Friese, M. A., & Fugger, L. (2009) · Annals of Neurology · doi:10.1002/ana.21744 · Cited by 171
Schreibelt, G., van Horssen, J., van Rossum, S., Dijkstra, C. D., Drukarch, B., & de Vries, H. E. (2007) · Brain Research Reviews · doi:10.1016/j.brainresrev.2007.07.005 · Cited by 171
Self-citationEvidence for Polygenic Susceptibility to Multiple Sclerosis—The Shape of Things to Come
The International Multiple Sclerosis Genetics Consortium (IMSGC) (2010) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2010.02.027 · Cited by 169
Schreibelt, G., Musters, R. J. P., Reijerkerk, A., de Groot, L. R., van der Pol, S. M. A., Hendrikx, E. M. L., Döpp, E. D., Dijkstra, C. D., Drukarch, B., & de Vries, H. E. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.4.2630 · Cited by 167
Sharma, R., Fischer, M.-T., Bauer, J., Felts, P. A., Smith, K. J., Misu, T., Fujihara, K., Bradl, M., & Lassmann, H. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0704-z · Cited by 164
Self-citationDysferlin Is a New Marker for Leaky Brain Blood Vessels in Multiple Sclerosis
Hochmeister, S., Grundtner, R., Bauer, J., Engelhardt, B., Lyck, R., Gordon, G., Korosec, T., Kutzelnigg, A., Berger, J. J., Bradl, M., et al. (2006) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/01.jnen.0000235119.52311.16 · Cited by 160
Self-citationKrishnamoorthy, G., Saxena, A., Mars, L. T., Domingues, H. S., Mentele, R., Ben‐Nun, A., Lassmann, H., Dornmair, K., Kurschus, F. C., Liblau, R., et al. (2009) · Nature Medicine · doi:10.1038/nm.1975 · Cited by 155
Self-citationSaxena, A., Bauer, J., Scheikl, T., Zappulla, J. P., Audebert, M., Desbois, S., Waisman, A., Lassmann, H., Liblau, R., & Mars, L. T. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.3.1617 · Cited by 145
Self-citationDavenport, H. (1947) · Journal of the London Mathematical Society · doi:10.1112/jlms/s1-22.2.100 · Cited by 140
Oxidative damage to DNA in plaques of MS brains
Vladimirova, O. V., O'Connor, J. J., Cahill, A., Alder, H., Butunoi, C., & Kálmán, B. (1998) · Multiple Sclerosis Journal · doi:10.1177/135245859800400503 · Cited by 139
The complex world of oligodendroglial differentiation inhibitors
Kremer, D., Aktaş, O., Hartung, H., & Küry, P. (2011) · Annals of Neurology · doi:10.1002/ana.22415 · Cited by 137
Parratt, J. D. E., & Prineas, J. W. (2010) · Multiple Sclerosis Journal · doi:10.1177/1352458510382324 · Cited by 135
Nrf2 and DJ1 are consistently upregulated in inflammatory multiple sclerosis lesions
van Horssen, J., Drexhage, J., Flor, T., Gerritsen, W. H., van der Valk, P., & de Vries, H. E. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.07.013 · Cited by 133
Multiple Sclerosis Pathology: Evolution of Pathogenetic Concepts
Lassmann, H. (2005) · Brain Pathology · doi:10.1111/j.1750-3639.2005.tb00523.x · Cited by 132
Self-citationElevated myeloperoxidase activity in white matter in multiple sclerosis
Gray, E., Thomas, T. L., Betmouni, S., Scolding, N. J., & Love, S. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2008.08.035 · Cited by 127
Bizzozero, O. A., DeJesus, G., Callahan, K., & Pastuszyn, A. (2005) · Journal of Neuroscience Research · doi:10.1002/jnr.20587 · Cited by 127
Lassmann, H. (2011) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2011.01189.x · Cited by 123
Self-citationDistribution of transferrin and ferritin binding in normal and multiple sclerotic human brains
Hulet, S. W., Powers, S. K., & Connor, J. R. (1999) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(99)00077-5 · Cited by 118
Mechanisms of neurodegeneration shared between multiple sclerosis and Alzheimer’s disease
Lassmann, H. (2011) · Journal of Neural Transmission · doi:10.1007/s00702-011-0607-8 · Cited by 112
Self-citationOxidized phosphatidylcholine is a marker for neuroinflammation in multiple sclerosis brain
Qin, J., Goswami, R., Balabanov, R. D., & Dawson, G. (2007) · Journal of Neuroscience Research · doi:10.1002/jnr.21206 · Cited by 108
Inhibiting poly(ADP-ribose) polymerase: a potential therapy against oligodendrocyte death
Veto, S., Acs, P., Bauer, J., Lassmann, H., Berente, Z., Setalo, G., Borgulya, G., Sumegi, B., Komoly, S., Gallyas, F., et al. (2010) · Brain · doi:10.1093/brain/awp337 · Cited by 107
Self-citationZiabreva, I., Campbell, G. R., Rist, J. M., Zambonin, J. L., Rorbach, J., Wydro, M. M., Lassmann, H., Franklin, R. J. M., & Mahad, D. (2010) · Glia · doi:10.1002/glia.21052 · Cited by 103
Self-citationMultiple sclerosis therapeutics
Wiendl, H., & Hohlfeld, R. (2009) · Neurology · doi:10.1212/01.wnl.0000344417.42972.54 · Cited by 93
Experimental Autoimmune Encephalomyelitis
Rao, P., & Segal, B. M. (2004) · Humana Press eBooks · doi:10.1385/1-59259-805-6:363 · Cited by 83
Novel CD8+ Treg suppress EAE by TGF‐β‐ and IFN‐γ‐dependent mechanisms
Chen, M., Yan, B., Kozoriz, D., & Weiner, H. L. (2009) · European Journal of Immunology · doi:10.1002/eji.200939441 · Cited by 83
Activated microglia cause superoxide-mediated release of iron from ferritin
Yoshida, T., Tanaka, Μ., Sotomatsu, A., & Hirai, S. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)11490-n · Cited by 79
Zeis, T., Probst, A., Steck, A. J., Stadelmann, C., Brück, W., & Schaeren‐Wiemers, N. (2009) · Brain Pathology · doi:10.1111/j.1750-3639.2008.00231.x · Cited by 76
NAD(P)H:quinone oxidoreductase 1 expression in multiple sclerosis lesions
van Horssen, J., Schreibelt, G., Bø, L., Montagne, L., Drukarch, B., Muiswinkel, F. L. V., & de Vries, H. E. (2006) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2006.04.013 · Cited by 71
Tremor-correlated neuronal activity in the subthalamic nucleus of Parkinsonian patients
Amtage, F., Henschel, K., Schelter, B. O., Vesper, J., Timmer, J., Lücking, C. H., & Hellwig, B. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2008.06.087 · Cited by 70
Linker, R. A., Rott, E., Hofstetter, H. H., Hanke, T., Toyka, K. V., & Gold, R. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.12.017 · Cited by 57
Bečanović, K., Jagodic, M., Sheng, J. R., Dahlman, I. A., Aboul‐Enein, F., Wallström, E., Olofsson, P., Holmdahl, R., Lassmann, H., & Olsson, T. P. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.10.6055 · Cited by 52
Self-citationMolecular analysis of iron overload in β2-microglobulin-deficient mice
Muckenthaler, M. U., Rodrigues, P., Macedo, M. G., Miñana, B., Brennan, K., Cardoso, E. M., Hentze, M. W., & de Sousa, M. A. B. (2004) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2004.05.003 · Cited by 43
Santos, M. M., Clevers, H. C., de Sousa, M. A. B., & Marx, J. J. M. (1998) · Blood · doi:10.1182/blood.v91.8.3059.3059_3059_3065 · Cited by 42
Hickey, W. F., Cohen, J. A., & Burns, J. B. (1987) · Cellular Immunology · doi:10.1016/0008-8749(87)90311-x · Cited by 34
Gene expression profiling in multiple sclerosis brain
Dutta, R., & Trapp, B. D. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.12.003 · Cited by 32
Taoufik, E., Tseveleki, V., Euagelidou, M., Emmanouil, M., Voulgari-Kokota, A., Haralambous, S., & Probert, L. (2007) · Neurodegenerative Diseases · doi:10.1159/000109936 · Cited by 18
Activation of p21ras by nerve growth factor in neuroblastoma cells
Burchill, S. A., Berry, P. A., & Lewis, I. J. (1995) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(95)00163-v · Cited by 16
Diagnostic criteria for primary progressive mutiple sclerosis: a position paper.
(2000) · Pure Amsterdam UMC · doi:10.1002/1531-8249(200006)47:6 · Cited by 2
(2000) · doi:10.1002/1531-8249(200012)48:6
Cited by
Interrelation of Oxidative Stress and Inflammation in Neurodegenerative Disease: Role of TNF
Fischer, R., & Maier, O. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/610813 · Cited by 731
Buendia, I., Michalska, P., Navarro, E., Gameiro, I., Egea, J., & León, R. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.11.003 · Cited by 678
Fischer, M. T., Sharma, R., Lim, J. L., Haider, L., Frischer, J. M., Drexhage, J., Mahad, D., Bradl, M., van Horssen, J., & Lassmann, H. (2012) · Brain · doi:10.1093/brain/aws012 · Cited by 507
Self-citationNADPH oxidase in brain injury and neurodegenerative disorders
Ma, M. W., Wang, J., Zhang, Q., Wang, R., Dhandapani, K. M., Vadlamudi, R. K., & Brann, D. W. (2017) · Molecular Neurodegeneration · doi:10.1186/s13024-017-0150-7 · Cited by 432
Mitochondrial dysfunction contributes to neurodegeneration in multiple sclerosis
Witte, M. E., Mahad, D. J., Lassmann, H., & van Horssen, J. (2014) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2013.11.007 · Cited by 278
Self-citation
Metadata
- Authors
- Lassmann, H., & van Horssen, J.
- Venue
- FEBS Letters
- Publisher
- Wiley
- Published
- 2011-08-16
- Volume
- 585
- Issue
- 23
- Pages
- 3715-3723
- ISSN
- 0014-5793 (ISSN-L)
- 1873-3468
- OpenAlex
- W2095370244
- Cited by
- 294
- References
- 120
- FWCI
- 18.81
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.